Page last updated: 2024-08-22

betamethasone valerate and Head and Neck Neoplasms

betamethasone valerate has been researched along with Head and Neck Neoplasms in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's2 (100.00)2.80

Authors

AuthorsStudies
Funahara, M; Hasegawa, T; Kawashita, Y; Kojima, Y; Murata, M; Nakahara, H; Otsuru, M; Saito, T; Shibuya, Y; Soutome, S; Umeda, M; Yamada, SI; Yamamura, Y; Yoshimatsu, M1
Kumari, R; Menon, A; Prem, SS1

Trials

2 trial(s) available for betamethasone valerate and Head and Neck Neoplasms

ArticleYear
Preventive effects of betamethasone valerate ointment for radiation-induced severe oral mucositis in patients with oral or oropharyngeal cancer: protocol for a multicentre, phase II, randomised controlled trial (Bet-ROM study).
    BMJ open, 2022, Jan-17, Volume: 12, Issue:1

    Topics: Betamethasone Valerate; Clinical Trials, Phase II as Topic; Head and Neck Neoplasms; Humans; Multicenter Studies as Topic; Ointments; Oropharyngeal Neoplasms; Radiation Injuries; Randomized Controlled Trials as Topic; Stomatitis

2022
Topical Betamethasone Valerate As a Prophylactic Agent to Prevent Acute Radiation Dermatitis in Head and Neck Malignancies: A Randomized, Open-Label, Phase 3 Trial.
    International journal of radiation oncology, biology, physics, 2021, 01-01, Volume: 109, Issue:1

    Topics: Acute Disease; Administration, Topical; Adult; Aged; Aged, 80 and over; Betamethasone Valerate; Female; Head and Neck Neoplasms; Humans; Male; Middle Aged; Radiodermatitis

2021